What is the immediate management for a patient presenting with Posterior Reversible Encephalopathy Syndrome (PRES)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Management of Posterior Reversible Encephalopathy Syndrome (PRES)

The immediate management of PRES requires urgent identification and removal of triggering factors, very stringent blood pressure control, and supportive care to prevent permanent neurological sequelae. 1

Step 1: Identify and Address Triggering Factors

  • Immediately discontinue offending medications:
    • Immunosuppressants
    • Chemotherapy agents
    • Anti-angiogenic drugs 1
  • For pregnancy-related PRES (eclampsia/pre-eclampsia):
    • Consider immediate delivery to remove the triggering factor 1
  • Address underlying conditions:
    • Autoimmune disorders
    • Renal impairment/failure 1

Step 2: Blood Pressure Management

  • Implement very stringent blood pressure control:
    • Target gradual reduction to avoid cerebral hypoperfusion 1
    • For severe hypertension (systolic BP ≥220 mmHg), consider IV antihypertensives 2, 1
    • Preferred IV medications include labetalol, with nifedipine as an oral option 2
    • IV hydralazine can be used as a second-line option 2

Step 3: Management of Cerebral Edema and Elevated Intracranial Pressure

  • Elevate head of bed to 30 degrees to decrease hydrostatic pressure and cerebral edema 2, 1
  • For patients with evidence of cerebral edema on imaging or signs of increased intracranial pressure:
    • Administer hyperosmolar therapy with either:
      • Mannitol: initial dose 0.5-1 g/kg IV; maintenance 0.25-1 g/kg every 6 hours (monitor serum osmolality) 2
      • Hypertonic 3% saline: initial dose 5 ml/kg IV over 15 minutes; maintenance 1 ml/kg/hour IV to target serum sodium 150-155 meq/l 2
    • Consider hyperventilation to achieve PaCO2 of 30-40 mmHg for acute management of intracranial hypertension 2
    • Monitor electrolytes every 4-6 hours 2

Step 4: Seizure Management

  • For active seizures:
    • Administer benzodiazepines for acute seizure control 1
    • Follow with appropriate antiepileptic treatment 1
  • Consider prophylactic anticonvulsants in high-risk patients 1

Step 5: Supportive Care

  • Implement vigilant supportive care:
    • Aspiration precautions
    • IV hydration
    • Avoid medications that cause CNS depression 1
  • Monitor neurological status closely for any deterioration 1
  • In rare cases of malignant intracranial hypertension refractory to medical management, surgical decompression may be necessary 3, 4

Special Considerations and Monitoring

  • Perform regular neurological assessments to detect early signs of deterioration
  • MRI is the gold standard for diagnosis and monitoring response to treatment 1
  • Monitor for complications:
    • Hemorrhagic transformation 5
    • Refractory intracranial hypertension 3
    • Permanent neurological deficits 1

Prognostic Factors

  • Poor outcomes are associated with:
    • Altered sensorium
    • Extensive cerebral edema
    • Presence of hemorrhage on imaging
    • Delayed control of causative factors 1
  • With appropriate management, PRES is typically reversible within 2 weeks 1
  • Delayed diagnosis and treatment may lead to permanent neurological sequelae 1, 6

Remember that early recognition and aggressive management of PRES are crucial to prevent irreversible neurological damage. The syndrome is typically reversible with prompt treatment of the underlying cause and careful blood pressure management.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.